This comprehensive molecular panel identifies the most common and clinically significant infections affecting women’s reproductive and sexual health.
Includes detection for:
- Bacterial vaginosis markers (Gardnerella, Atopobium)
- Candida spp., Trichomonas vaginalis
- Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Ureaplasma spp.
Benefits: - Early detection of co-infections
- Minimally invasive, patient-friendly sample collection
- Optimizes treatment and reduces complications
